4 recruiting, 3 completed, 2 active not recruiting, 1 unknown. 5 Not applicable, 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Recruiting 3, Completed 1, Withdrawn 1 |
| Phase 2 | 4 | Active not recruiting 1, Completed 1, Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow High-Dose Rate Brachytherapy: new trials by email Literature Review of High-Dose Rate Brachytherapy trials Research Report on High-Dose Rate Brachytherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer Biopsy Procedure, Biospecimen Collection, High-Dose Rate Brachytherapy - Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8 | Not applicable | Recruiting | Jonsson Comprehensive Cancer Center | 45 | 2026-05-11 | 2026-05-22 |
| Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda Hypofractionated Radiation Therapy, Conventional Fractionated Radiotherapy, Cisplatin - Cervical Cancer, Cervix Cancer | Phase 2 | Recruiting | Uganda Cancer Institute | 278 | 2026-03-11 | 2026-03-27 |
| High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma High-Dose Rate Brachytherapy, Stereotactic Body Radiation Therapy - Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8 | Not applicable | Recruiting | Jonsson Comprehensive Cancer Center | 52 | 2021-08-20 | 2026-08-20 |
| Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer High-Dose Rate Brachytherapy, Proton Beam Radiation Therapy, Quality-of-Life Assessment - Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 | Not applicable | Recruiting | Emory University | 30 | 2021-02-01 | 2026-02-17 |
| Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer High-Dose Rate Brachytherapy, Quality-of-Life Assessment, Questionnaire Administration - Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8 | Not applicable | Withdrawn | Jonsson Comprehensive Cancer Center | 2020-04-03 | 2020-11-06 | |
| Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer Biospecimen Collection, Brachytherapy, Cisplatin - Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 21 | 2019-09-18 | 2026-10-30 |
| Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer High-Dose Rate Brachytherapy, Quality-of-Life Assessment, Questionnaire Administration - Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 | Phase 2 | Active not recruiting | Rutgers, The State University of New Jersey | 14 | 2019-07-17 | 2025-09-17 |
| Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer Nimotuzumab, Cisplatin, external-beam radiation - Neoplasms, Cervical Adenosquamous Cell Carcinoma | Phase 2 | Unknown | Zhujiang Hospital | 100 | 2018-03-20 | 2018-08-13 |
| Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation High-Dose Rate Brachytherapy, Hyperthermia Treatment, Laboratory Biomarker Analysis - Recurrent Prostate Carcinoma | Not applicable | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 3 | 2017-03-21 | 2026-02-20 |
| Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery Accelerated Partial Breast Irradiation, High-Dose Rate Brachytherapy, Questionnaire Administration - Ductal Breast Carcinoma In Situ, Estrogen Receptor Positive | Phase 2 | Completed | Rutgers, The State University of New Jersey | 200 | 2015-07-15 | 2023-05-15 |
| Experiences With HDR-brachytherapy in Norway High-Dose Rate Brachytherapy - Prostate Cancer | Completed | Oslo University Hospital | 325 | 2004-01-01 | 2017-05-25 |
Prostatic Neoplasms (7) · Uterine Cervical Neoplasms (3) · Breast Neoplasms (1) · Carcinoma, Intraductal, Noninfiltrating (1) · Neoplasms (1) · Uterine Cervical Dysplasia (1)
Jonsson Comprehensive Cancer Center (3) · Rutgers, The State University of New Jersey (2) · Emory University (1) · National Cancer Institute (NCI) (1) · Oslo University Hospital (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · Uganda Cancer Institute (1) · Zhujiang Hospital (1)
United States (8) · China (1) · Norway (1) · Uganda (1)
Alan C Lee (2) · Bruce Haffty, MD (1) · Jessie DiNome, MD (1) · Lara Hathout (1) · Pretesh R Patel (1) · Sarah E Taylor (1) · Solomon Kibudde, MBChB, MMed. (1) · Stephanie M Yoon, MD (1) · Trude Wedde, MD (1)
D43TW009759 (1), P30CA072720 (1), P30CA138292 (1), UM1CA186690 (1)